Skip to main content
Equibles
GALT logo

GALT · Galectin Therapeutics Inc · Webcasts, Transcripts & Audio

Track GALT — free

Use GALT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GALT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.90 +0.14 (+3.72%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Going-concern doubt — flagged Aug 14, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These factors raise substantial doubt about the Company’s ability to continue as a going concern for a period of 12 months from the issuance date of these financial statements.”
View the 10-Q filed Aug 14, 2026
Market Cap
$393.31M
Shares
100.85M
Volume · Oct 2 220.51K Avg daily vol (3M) 394.37K

Galectin Therapeutics Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Galectin Therapeutics Inc (GALT), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →
Key facts CIK 1133416 CUSIP 363225202 13F (30d) 2 filings 2 filers Visit website